Level Bio AB (publ) (NGM:LEVBIO)
Sweden
· Delayed Price · Currency is SEK 0.350
-0.096 (-21.52%)
At close: Mar 9, 2026
Level Bio AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 2.49 | 1.08 | 3.63 | 7.84 | 5.86 | Upgrade
|
| Cash & Short-Term Investments | 2.49 | 1.08 | 3.63 | 7.84 | 5.86 | Upgrade
|
| Cash Growth | 130.43% | -70.29% | -53.71% | 33.76% | 312.78% | Upgrade
|
| Accounts Receivable | 5.53 | 6.09 | 4.43 | 5.73 | 8.57 | Upgrade
|
| Other Receivables | - | 0.5 | 0.59 | 0.52 | 0.45 | Upgrade
|
| Receivables | 5.53 | 6.58 | 5.01 | 6.25 | 9.01 | Upgrade
|
| Inventory | 3.86 | 3.72 | 4.38 | 5.7 | 6.62 | Upgrade
|
| Prepaid Expenses | - | 0.3 | 0.3 | 0.27 | 0.2 | Upgrade
|
| Other Current Assets | 0.89 | -0 | - | - | - | Upgrade
|
| Total Current Assets | 12.77 | 11.68 | 13.32 | 20.06 | 21.69 | Upgrade
|
| Property, Plant & Equipment | 0.04 | 0.08 | 0.12 | 0.12 | 0.08 | Upgrade
|
| Long-Term Investments | - | - | - | 0.78 | 0.48 | Upgrade
|
| Goodwill | - | 1.14 | 1.94 | 2.74 | 3.54 | Upgrade
|
| Other Intangible Assets | 0.94 | 1.67 | 2.81 | 3.96 | 4.89 | Upgrade
|
| Long-Term Deferred Tax Assets | 0.31 | 0.52 | 0.42 | 0.46 | 0.5 | Upgrade
|
| Long-Term Deferred Charges | - | 0.28 | 0.48 | 0.68 | 0.88 | Upgrade
|
| Other Long-Term Assets | - | 0 | 0 | 0 | 0 | Upgrade
|
| Total Assets | 14.05 | 15.37 | 19.09 | 28.8 | 32.06 | Upgrade
|
| Accounts Payable | - | 1.53 | 1.58 | 1.77 | 1.5 | Upgrade
|
| Accrued Expenses | - | 2.43 | 1.9 | 1.55 | 1.76 | Upgrade
|
| Short-Term Debt | - | 1.41 | 1.11 | - | - | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | 0.3 | 0.3 | Upgrade
|
| Current Income Taxes Payable | - | 0.04 | 0.06 | 0.08 | 0.01 | Upgrade
|
| Current Unearned Revenue | - | 2.45 | 1.61 | 1.62 | 1.9 | Upgrade
|
| Other Current Liabilities | 12.96 | 2.95 | 1.77 | 2.37 | 2.68 | Upgrade
|
| Total Current Liabilities | 12.96 | 10.81 | 8.03 | 7.69 | 8.15 | Upgrade
|
| Long-Term Debt | - | - | - | 0.3 | 0.6 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 0.11 | 0.38 | 0.65 | 0.92 | 1.2 | Upgrade
|
| Other Long-Term Liabilities | 0.34 | - | - | - | - | Upgrade
|
| Total Liabilities | 13.41 | 11.2 | 8.68 | 8.91 | 9.95 | Upgrade
|
| Common Stock | 0.64 | 0.74 | 0.69 | 0.69 | 0.69 | Upgrade
|
| Additional Paid-In Capital | - | 18.77 | 17.19 | 17.19 | 17.19 | Upgrade
|
| Retained Earnings | - | -15.33 | -7.46 | 2.02 | 4.24 | Upgrade
|
| Comprehensive Income & Other | - | 0 | - | - | - | Upgrade
|
| Shareholders' Equity | 0.64 | 4.18 | 10.41 | 19.89 | 22.11 | Upgrade
|
| Total Liabilities & Equity | 14.05 | 15.37 | 19.09 | 28.8 | 32.06 | Upgrade
|
| Total Debt | - | 1.41 | 1.11 | 0.6 | 0.9 | Upgrade
|
| Net Cash (Debt) | 2.49 | -0.33 | 2.52 | 7.24 | 4.96 | Upgrade
|
| Net Cash Growth | - | - | -65.16% | 45.93% | 2154.38% | Upgrade
|
| Net Cash Per Share | 0.04 | -0.01 | 0.04 | 0.11 | 0.08 | Upgrade
|
| Filing Date Shares Outstanding | 68.4 | 68.4 | 63.4 | 63.4 | 63.4 | Upgrade
|
| Total Common Shares Outstanding | 68.4 | 68.4 | 63.4 | 63.4 | 63.4 | Upgrade
|
| Working Capital | -0.2 | 0.87 | 5.29 | 12.37 | 13.54 | Upgrade
|
| Book Value Per Share | 0.01 | 0.06 | 0.16 | 0.31 | 0.35 | Upgrade
|
| Tangible Book Value | -0.3 | 1.37 | 5.67 | 13.19 | 13.68 | Upgrade
|
| Tangible Book Value Per Share | -0.00 | 0.02 | 0.09 | 0.21 | 0.22 | Upgrade
|
| Machinery | - | 3.48 | 3.48 | 3.44 | 3.33 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.